cd206 (Cell Signaling Technology Inc)
Structured Review
Cd206, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd206/pmc12992974-282-11-13
Average 86 stars, based on 1 article reviews
Images
Related Articles
Immunofluorescence:Article Title: Stem cell-derived biomimetic apoptotic vesicles enhance macrophage efferocytosis via C1qbp to accelerate diabetic wound healing Article Snippet: Samples were analyzed using a flow cytometer and the data were processed with FlowJo software. .. For immunofluorescence staining, RAW264.7 cells were fixed in 4% PFA, permeabilized with 1% Triton X-100 for 10 min, blocked with 1% BSA for 1 h at room temperature, and incubated overnight at 4 °C with the following primary antibodies: Staining:Article Title: Stem cell-derived biomimetic apoptotic vesicles enhance macrophage efferocytosis via C1qbp to accelerate diabetic wound healing Article Snippet: Samples were analyzed using a flow cytometer and the data were processed with FlowJo software. .. For immunofluorescence staining, RAW264.7 cells were fixed in 4% PFA, permeabilized with 1% Triton X-100 for 10 min, blocked with 1% BSA for 1 h at room temperature, and incubated overnight at 4 °C with the following primary antibodies: Incubation:Article Title: Stem cell-derived biomimetic apoptotic vesicles enhance macrophage efferocytosis via C1qbp to accelerate diabetic wound healing Article Snippet: Samples were analyzed using a flow cytometer and the data were processed with FlowJo software. .. For immunofluorescence staining, RAW264.7 cells were fixed in 4% PFA, permeabilized with 1% Triton X-100 for 10 min, blocked with 1% BSA for 1 h at room temperature, and incubated overnight at 4 °C with the following primary antibodies: Article Title: Regorafenib and Nifuroxazide exert enhanced suppression of hepatocellular carcinoma by inhibiting STAT3 and immune remodeling Article Snippet: Sections were then blocked with 5% normal goat serum (Beyotime Biotechnology, cat. no. C0265) for 30 min at room temperature to eliminate non-specific antibody binding. .. The prepared tumor sections were incubated with the following primary antibodies: anti-CD3 (1:200; OmnimAbs; cat. no. OM244830 ); anti-CD4 (1:200; Cell Signaling Technology, Inc.; cat. no. 25229); anti-CD8 (1:400; Cell Signaling Technology, Inc.; cat. no. 98941); Article Title: Disruption of the circadian rhythm induces acute pancreatitis via amino acid metabolism-mediated macrophage infiltration. Article Snippet: .. The sections were incubated overnight at 4°C with the following primary antibodies: anti-F4/80 (1:500, #70076 , CST), anti-CD86 (1:100, #19589, CST), other:Article Title: COX5A induces M2 macrophage polarization in chronic rhinosinusitis with nasal polyps through ROS generation Article Snippet: After boiling in a citric acid buffer (Servicebio, G1202) for antigen recovery, the tissue sections were blocked with 5% Bovine Serum Albumin (BSA) (Beyotime, P0023B) in TBST (Servicebio, G0001) and then incubated with primary antibodies against CD206(1:400,Cell Signaling Technology (CST), 24595), COX5A (1:500, ABclonal, A6437), and Article Title: COX5A induces M2 macrophage polarization in chronic rhinosinusitis with nasal polyps through ROS generation. Article Snippet: Immunofluorescence(mIF) After boiling in a citric acid buffer (Servicebio, G1202) for antigen recovery, the tissue sections were blocked with 5% Bovine Serum Albumin (BSA) (Beyotime, P0023B) in TBST (Servicebio, G0001) and then incubated with primary antibodies against CD206(1:400,Cell Signaling Technology (CST), 24595), COX5A (1:500, ABclonal, A6437), and Gene Expression:Article Title: CX3CL1-CX3CR1 signaling orchestrates malignant progression of prostate cancer through luminal progenitor-macrophage crosstalk. Article Snippet: Imaging was performed using a confocal laser scanning microscope (Nikon A2, Japan). .. The following primary antibodies were used: anti-F4/80 (1:200, Cat# 70076, Cell Signaling Technology, USA), Western Blot:Article Title: M2 macrophage-mediated tigecycline nanoparticles for combating CRKP pneumonia via antibacterial and immunomodulatory therapy. Article Snippet: Pneumonia caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) has a high mortality rate and exhibits multiple drug resistance, making current antibacterial treatments of limited efficacy.. To address the challenges of ineffective drug accumulation at the infection site and excessive inflammation leading to tissue damage, this study developed a cell-based nanobionic drug delivery system (denoted as PT@M2, PLGA-TIG nanoparticles loaded into M2 macrophages).. This system encapsulates poly(lactic-co-glycolic acid) (PLGA) loaded with tigecycline within M2-type macrophages, thereby achieving stable circulation, rapid release in acidic microenvironments, and targeted delivery to the lungs. |




